SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 107.87 |
| Enterprise Value ($M) | -23.67 |
| Book Value ($M) | 134.27 |
| Book Value / Share | 1.62 |
| Price / Book | 0.80 |
| NCAV ($M) | 82.00 |
| NCAV / Share | 0.99 |
| Price / NCAV | 1.32 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.40 |
| Return on Assets (ROA) | -0.54 |
| Return on Equity (ROE) | -0.81 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.75 |
| Current Ratio | 3.75 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 289.31 |
| Assets | 341.59 |
| Liabilities | 207.31 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 32.31 |
| Operating Income | -238.92 |
| Net Income | -237.09 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -210.28 |
| Cash from Investing | 162.15 |
| Cash from Financing | 56.03 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Deep Track Capital, LP | 0.00 | -100.00 | |
| 13G/A | Vanguard Group Inc | 8.09 | 0.00 | |
| 13G/A | State Street Corp | 3.00 | -46.37 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 394,064 | 1,477,666 | 26.67 | |
| 861,650 | 3,020,573 | 28.53 | |
| 377,602 | 1,371,016 | 27.54 | |
| 863,332 | 2,642,638 | 32.67 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DNLI – Denali Therapeutics Inc. | DSGN – Design Therapeutics, Inc. |
| DVAX – Dynavax Technologies Corporation | ELVN – Enliven Therapeutics, Inc. |
| ENTA – Enanta Pharmaceuticals, Inc. |